> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Mauna Kea Confocal Miniprobes
- URL: https://www.fdaweb.com/fda-clears-mauna-kea-confocal-miniprobes/
- Published: 2017-08-07T12:00:00.000Z
- Updated: 2026-09-14T22:39:29.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139324

FDA has cleared a Mauna Kea Technologies 510(k) for its CelioFlex UHD Confocal Miniprobes for use with the company’s Cellvizio laser endomicroscopy platform in robotic-assisted surgery procedures. The Miniprobes are intended to provide visualization of body cavities, organs, and canals during endoscopic and laparoscopic surgical procedures. The company says this is the 13th clearance covering the Cellvizio system. “We see the ability to instantaneously visualize and characterize tissue at the cellular level as a natural extension to robotic-assisted procedures and enabling data-driven surgery, which will in-part rely on advanced imaging and machine learning algorithms to provide reliable, real-time tissue information to surgeons,” the company says.